Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic study of Xuebijing injection in healthy adults
ChiCTR-ONRC-13003932Phase 4Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Nov 2013
- Countries
- 1
01
Overview
Phase 4, open-label trial of xuebijing (4 arms), sponsored by Shanghai Institute of Materia Medica. Primary endpoints: Plasma drug concentration, Urinary drug concentration and 2 more. Started Nov 2013; status: completed.
02
Drugs
xuebijing
Beyond the preview
Go deeper on ChiCTR-ONRC-13003932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-13003932.